Literature DB >> 9173898

Prothrombinase is protected from inactivation by tissue factor pathway inhibitor: competition between prothrombin and inhibitor.

J Franssen1, I Salemink, G M Willems, T C Wun, H C Hemker, T Lindhout.   

Abstract

The inhibition of prothrombinase by tissue factor pathway inhibitor (TFPI) has been studied in the presence and absence of prothrombin. The rate constant of association of prothrombinase with full-length TFPI was 2.1x10(7) M-1.s-1 and 0.05x10(7) M-1.s-1 for the reaction with C-terminus truncated TFPI (TFPI1-161). The rate constant of dissociation was 0.65x10(-4) s-1 in both cases. The rate constant of inhibition of prothrombinase by TFPI1-161 was similar to that of solution-phase factor Xa. In contrast, phospholipids and factor Va enhanced the association rate of the reaction between factor Xa and full-length TFPI by approx. 20-fold. Although TFPI, and in particular the full-length variant of the molecule, is a potent inhibitor of prothrombinase (overall inhibition constant of 3 pM), we also found that prothrombin competed very effectively with TFPI for the active site of factor Xa in the prothrombinase complex. A 50% reduction of the rate constant of inhibition was measured in the presence of 4 nM prothrombin, i.e. 0.2% of the plasma concentration of prothrombin. The physiological significance of TFPI as an inhibitor of prothrombinase activity is thus questionable.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9173898      PMCID: PMC1218311          DOI: 10.1042/bj3230033

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  27 in total

1.  Comparison of the esterase activities of trypsin, plasmin, and thrombin on guanidinobenzoate esters. Titration of the enzymes.

Authors:  T Chase; E Shaw
Journal:  Biochemistry       Date:  1969-05       Impact factor: 3.162

2.  Titration of activated bovine Factor X.

Authors:  R L Smith
Journal:  J Biol Chem       Date:  1973-04-10       Impact factor: 5.157

3.  Factor Xa enhances the binding of tissue factor pathway inhibitor to acidic phospholipids.

Authors:  S Valentin; I Schousboe
Journal:  Thromb Haemost       Date:  1996-05       Impact factor: 5.249

4.  Factor-Xa inactivation by antithrombin. 3. Evidence for biological stabilization of factor Xa by factor V-phospholipid complex.

Authors:  E Marciniak
Journal:  Br J Haematol       Date:  1973-03       Impact factor: 6.998

5.  Activation of decarboxyfactor X by a protein from Russell's viper venom. Purification and partial characterization of activated decarboxyfactor X.

Authors:  M J Lindhout; B H Kop-Klaassen; H C Hemker
Journal:  Biochim Biophys Acta       Date:  1978-04-26

6.  Factor Va-factor Xa interaction. Effects of phospholipid vesicles of varying composition.

Authors:  T Lindhout; J W Govers-Riemslag; P van de Waart; H C Hemker; J Rosing
Journal:  Biochemistry       Date:  1982-10-26       Impact factor: 3.162

7.  The role of phospholipids and factor Va in the prothrombinase complex.

Authors:  J Rosing; G Tans; J W Govers-Riemslag; R F Zwaal; H C Hemker
Journal:  J Biol Chem       Date:  1980-01-10       Impact factor: 5.157

8.  Protection of factor Xa from neutralization by the heparin-antithrombin complex.

Authors:  J M Teitel; R D Rosenberg
Journal:  J Clin Invest       Date:  1983-05       Impact factor: 14.808

9.  Activation of human prothrombin by stoichiometric levels of staphylocoagulase.

Authors:  H Hendrix; T Lindhout; K Mertens; W Engels; H C Hemker
Journal:  J Biol Chem       Date:  1983-03-25       Impact factor: 5.157

10.  Pathways in the activation of human coagulation factor X.

Authors:  K Mertens; R M Bertina
Journal:  Biochem J       Date:  1980-03-01       Impact factor: 3.857

View more
  6 in total

1.  Fusion proteins comprising annexin V and Kunitz protease inhibitors are highly potent thrombogenic site-directed anticoagulants.

Authors:  Hsiu-Hui Chen; Cristina P Vicente; Li He; Douglas M Tollefsen; Tze-Chein Wun
Journal:  Blood       Date:  2005-01-27       Impact factor: 22.113

Review 2.  Biology of tissue factor pathway inhibitor.

Authors:  Jeremy P Wood; Paul E R Ellery; Susan A Maroney; Alan E Mast
Journal:  Blood       Date:  2014-03-11       Impact factor: 22.113

3.  TFPIα interacts with FVa and FXa to inhibit prothrombinase during the initiation of coagulation.

Authors:  Jeremy P Wood; Helle H Petersen; Bingke Yu; Xiaoai Wu; Ida Hilden; Alan E Mast
Journal:  Blood Adv       Date:  2017-12-26

4.  Reduced Prothrombinase Inhibition by Tissue Factor Pathway Inhibitor Contributes to the Factor V Leiden Hypercoagulable State.

Authors:  Jeremy P Wood; Lisa M Baumann Kreuziger; Paul E R Ellery; Susan A Maroney; Alan E Mast
Journal:  Blood Adv       Date:  2017-02-14

5.  Tissue factor pathway inhibitor-alpha inhibits prothrombinase during the initiation of blood coagulation.

Authors:  Jeremy P Wood; Matthew W Bunce; Susan A Maroney; Paula B Tracy; Rodney M Camire; Alan E Mast
Journal:  Proc Natl Acad Sci U S A       Date:  2013-10-14       Impact factor: 11.205

6.  Blocking inhibition of prothrombinase by tissue factor pathway inhibitor alpha: a procoagulant property of heparins.

Authors:  Jeremy P Wood; Lisa M Baumann Kreuziger; Umesh R Desai; Alan E Mast
Journal:  Br J Haematol       Date:  2016-06-15       Impact factor: 6.998

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.